Letco Medical LLC is recalling approximately 3,685 jars of Estriol USP Micronized, a prescription hormone therapy medication, because it was found to be subpotent. Subpotent means the product does not contain the full strength of the active ingredient listed on the label, which can lead to ineffective treatment and the return of symptoms. This recall affects various sizes ranging from 1 gram to 1 kilogram that were distributed between 2017 and 2020. Consumers should contact their healthcare provider or pharmacist for guidance on their treatment plan.
The medication contains less than the required amount of the active ingredient, which may result in patients receiving a lower dose than prescribed. This lack of full potency can cause the medication to fail in treating the patient's condition effectively.
Refund or medication replacement
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.